About 8,800,000 results
Open links in new tab
GSK says RSV vaccine protects against disease over three seasons
GSK presents positive data for AREXVY, its respiratory syncytial …
GSK touts 3-year data on RSV shot Arexvy after CDC's narrower …
GSK RSV shot 43% effective against severe disease in third year
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
US FDA approves GSK’s AREXVY, the world’s first respiratory …
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
New data for AREXVY, GSK’s RSV vaccine, show potential to help …
US FDA approves GSK’s Arexvy, the world’s first respiratory …
GSK's RSV Vaccine Offers Protection Over Three Seasons, Study …
- Some results have been removed